跳至主要内容
临床试验/NCT04988230
NCT04988230已完成不适用

Effects of Time-Restricted Feeding on Nonalcoholic Fatty Liver Disease in Obese Adults: a 12-month Randomized Clinical Trial

Nanfang Hospital, Southern Medical University1 个研究点 分布在 1 个国家目标入组 88 人开始时间: 2021年7月30日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
88
试验地点
1
主要终点
Change in intrahepatic fat content

研究概览

简要总结

Time restricted feeding (TRF) is a novel type of intermittent calorie restriction diet that involves eating a daily period of 8 hours or less. This is a 6-month follow-up study of TREATY-FLD trial to evaluate the effect of time restricted feeding (TRF) on hepatic fat contents and cardiometabolic risk factors in obese adults over 6 months compared to continuous energy restriction (CER).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Man or women aged≥18 years;
  • Subjects with NAFLD determined by MRI (intrahepatic triglyceride content ≥5%);
  • Body mass index (BMI)of 28.0 to 45.0 kg/m2;

排除标准

  • History of alcoholic liver disease, chronic viral hepatitis, drug-induced hepatitis, autoimmune hepatitis, cirrhosis, and liver cancer;
  • History of HIV, or active pulmonary tuberculosis;
  • Diagnosis of type 1 and type 2 diabetes;
  • History of malignant tumors;
  • Serious liver dysfunction or chronic kidney disease (AST or ALT > 3 times the upper limit of normal, or eGFR<30 ml/min/1.73 m2);
  • Significant alcohol consumption in the past six months (Consumed more than 20 g/day for women or 30 g/day for men);
  • History of serious cardiovascular or cerebrovascular disease (angina, myocardial infarction or stroke) in the past 6 months;
  • History of severe gastrointestinal diseases or gastrointestinal surgery in the past 12 months;
  • History of Cushing's syndrome, hypothyroidism, acromegaly, hypothalamic obesity;
  • Being a smoker or having been a smoker in the 3 months prior to their screening visit;
  • Taking medications affecting weight or energy intake/energy expenditure in the last 6 months, including weight loss medications, antipsychotic drugs or other medications as determined by the study physician;
  • Currently participating in weight loss programs or weight change in the past 3 months (> 5% current body weight) ;
  • Women who are pregnant or plan to become pregnant;
  • Patients who cannot be followed for 24 months (due to a health situation or migration);
  • Patients who are unwilling or unable to give informed consent.

结局指标

主要结局

Change in intrahepatic fat content

时间窗: Baseline,month 6, month 12.

Intrahepatic fat content will be assessed by MR mDixon-Quant

次要结局

  • Change in body fat(Baseline,month 6, month 12.)
  • Change in waist circumference(Baseline,month 6, month 12.)
  • Change in HbA1c level(Baseline,month 6, month 12.)
  • Change in serum ALT level(Baseline,month 6, month 12.)
  • Change in visceral fat(Baseline,month 6, month 12.)
  • Change in liver fiber(Baseline,month 6, month 12.)
  • Change in body weight(Baseline,month 6, month 12.)
  • Change in Systolic blood pressure(Baseline,month 6, month 12.)
  • Change in LDL-c level(Baseline,month 6, month 12.)
  • Change in insulin sensitivity(Baseline,month 6, month 12.)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Huijie Zhang

Deputy director of Department of Endocrinology and Metabolism

Nanfang Hospital, Southern Medical University

研究点 (1)

Loading locations...

相似试验

Time Restricted Feeding on Nonalcoholic Fatty Liver... | 临床试验